INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PBE INVESCO BIOTECHNOLOGY & GENOME ETF

盘前交易 09-17 09:14:33 EDT

93.37

+0.26

+0.28%

盘前93.37

+0.000.00%

07:00 EDT

最高94.05	最低92.87	成交量2.23万
今开93.99	昨收93.11	日振幅1.27%
总市值4.05亿	流通市值4.05亿	总股本434.00万
成交额209.35万	换手率0.51%	流通股本434.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PBE","market":"US","secType":"STK","nameCN":"INVESCO BIOTECHNOLOGY & GENOME ETF","latestPrice":93.3693,"timestamp":1789588800000,"preClose":93.11,"halted":0,"volume":22303,"hourTrading":{"tag":"盘前","latestPrice":93.3693,"preClose":93.3693,"latestTime":"07:00 EDT","volume":1,"amount":93.3693,"timestamp":1789642840517,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.0027848781011706163,"floatShares":4340000,"shares":4340000,"eps":1.793292,"marketStatus":"盘前交易","change":0.2593,"latestTime":"09-17 09:14:33 EDT","open":93.99,"high":94.05,"low":92.87,"amount":2093529.97492,"amplitude":0.012673,"askPrice":106.62,"askSize":100,"bidPrice":80.15,"bidSize":100,"shortable":3,"etf":1,"ttmEps":1.793292,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":93.3693,"sharesOutstanding":3180000,"nav":93.02867,"aum":405605001.2,"dividendRate":0.0166,"bidAskSpread":0.001979,"preHourTrading":{"tag":"盘前","latestPrice":93.3693,"preClose":93.3693,"latestTime":"07:00 EDT","volume":1,"amount":93.3693,"timestamp":1789642840517,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":92.89213,"preClose":93.3693,"latestTime":"19:30 EDT","volume":12,"amount":1120.613,"timestamp":1789601405975,"change":-0.47717,"changeRate":-0.005111,"amplitude":0},"volumeRatio":1.848754094790756,"impliedVol":0.1139,"impliedVolPercentile":0.036},"requestUrl":"/m/hq/s/PBE/tweets","defaultTab":"tweets","newsList":[{"id":"2667267605","title":"百时美施贵宝就安进拟推出的Opdivo生物类似药提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2667267605","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667267605?lang=zh_cn&edition=full","pubTime":"2026-09-16 10:15","pubTimestamp":1789524901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2322448957.HKD","LU0058720904.USD","LU0320765992.SGD","AMGN","LU0109394709.USD","LU1236620834.HKD","BMY","LU1670711123.USD","PPH","LU0868494617.USD","LU1023059063.AUD","LU2272731600.USD","BK4566","LU1983299246.USD","IHE","BK4139","BK4559","LU2125154778.USD","LU0061475181.USD","BK4585","LU0289739699.SGD","BK4533","IE00BSNM7G36.USD","LU2272731865.HKD","PBE","LU1883839398.USD","XPH","IE0009355771.USD","LU0225284248.USD","LU0225771236.USD","LU1989771016.USD","TBXU","BK4534","LU0114720955.EUR","IBB","LU1868837300.USD","FTXH","BBH","LU1236620750.USD","LU1992135399.USD","LU2473716301.USD","LU2468319806.SGD","BIB","BK4588","IE00B4R5TH58.HKD","LU1868836591.USD","LU1868836757.USD","IBBQ","LU1261432733.SGD","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股价盘后跌超2%，因其三期临床试验结果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666571008?lang=zh_cn&edition=full","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNOM","SYNB","LU2322448791.USD","TMED","LFSC","HELX","LU1992135399.USD","PBE","BK4585","FTXH","BBH","CANC","LU2272731600.USD","LU2272731865.HKD","RSPH","PSCH","IBB","IDNA","IEIH","MRNY","XBIX","BK4588","FBT","BME","RXL","AZNH","LU2322448957.HKD","PJP","XPH","IEHS","LU2272731782.SGD","WDNA","IBRN","BIOY","LU2473716301.USD","IYH","MEDI","IE00B5TLWC47.USD","BBP","MRNX","LU1992135472.HKD","BIB","PPH","PBPH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666712586","title":"安进（AMGN）联合疗法III期临床达主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=2666712586","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666712586?lang=zh_cn&edition=full","pubTime":"2026-09-09 16:59","pubTimestamp":1788944360,"startTime":"0","endTime":"0","summary":"金吾财经 | 安进公布，双特异性T细胞衔接器Imdelltra联合阿斯利康PD-L1抑制剂英飞凡，在广泛期小细胞肺癌的后期临床试验中实现总生存期延长。这家加州生物制药企业披露III期DeLLphi-305研究中期数据，该试验达成广泛期小细胞肺癌患者总生存期主要终点。该项全球试验评估该组合作为一线维持治疗，受试者既往接受过包含英飞凡的治疗且病情未发生进展。研究同时达成无进展生存期、客观缓解率两项次要终点。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NjNkZWQ4NGZiN2I3MDYxNDlhOTlmZGM4ZTUwODkzNDUzNTE2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305840","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","LU0029864427.USD","IE0002141913.USD","LU0289739699.SGD","BK4568","BK4585","BK4566","LU0128525929.USD","TBXU","LU1267930573.SGD","BBH","IE00B4R5TH58.HKD","LU2112291526.USD","LU2237443895.HKD","LU2089984988.USD","IE00BJJMRZ35.SGD","SG9999001440.SGD","BIB","LU2456880835.USD","LU0708994859.HKD","LU0058720904.USD","LU0868494617.USD","BK4599","BK4139","LU2242646821.SGD","LU2468319806.SGD","IBBQ","LU1829250122.USD","LU2237443382.USD","LU1023059063.AUD","LU2462157665.USD","PJP","BK4533","IE00BFTCPJ56.SGD","LU1571399168.USD","AZN","AZNH","LU0889565916.HKD","LU0122379950.USD","IBB","BK4534","LU0432979614.USD","LU2236285917.USD","LU2242652126.USD","PBE","IE00B2B36J28.USD","LU2237443622.USD","AMGN","LU2237443978.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666309213","title":"安进-阿斯利康肺癌联合用药在后期临床试验中显著提升生存率","url":"https://stock-news.laohu8.com/highlight/detail?id=2666309213","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666309213?lang=zh_cn&edition=full","pubTime":"2026-09-09 10:39","pubTimestamp":1788921579,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4534","BK4139","IE00B4R5TH58.HKD","PSYK","BK4599","LU1057294990.SGD","LU0058720904.USD","LU1023059063.AUD","LU0889565916.HKD","TBXU","AMGN","IE00B2B36J28.USD","LU2468319806.SGD","BK4585","PJP","SG9999001440.SGD","LU1983299246.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","MDTX","LU0868494617.USD","LU0320765992.SGD","BMED","PBE","BK4588","BIB","LU1061106388.HKD","IBBQ","IBBJ","BBH","LU0122379950.USD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4566","LU2242652126.USD","IBB","IE00BJJMRZ35.SGD","BK4533","BK4581","LU2242646821.SGD","LU2112291526.USD","LU2089984988.USD","LU0289739699.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112638879","title":"市场风向标：安进股价遭受重创","url":"https://stock-news.laohu8.com/highlight/detail?id=1112638879","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112638879?lang=zh_cn&edition=full","pubTime":"2026-09-09 05:35","pubTimestamp":1788903338,"startTime":"0","endTime":"0","summary":"“这对安进而言，堪称最糟糕的结局。”——巴克莱分析师艾米丽·菲尔德如此评价。此前，诺华制药公布了其心脏病药物令人失望的试验结果，这一披露不仅让诺华自身承压，更给安进旗下一款重磅药物蒙上了厚厚的阴影。","market":"hk","thumbnail":"https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e5b05f9c7e258c0791b0ff14e4bfadad"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","IBB","IE00B2B36J28.USD","BK4139","LU2468319806.SGD","TBXU","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4599","LU0320765992.SGD","LU2112291526.USD","LU0868494617.USD","IE0002141913.USD","BK4534","BK4566","LU1983299246.USD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4533","LU0122379950.USD","BIB","BK4581","SG9999001440.SGD","PBE","LU1571399168.USD","BK4588","LU1061106388.HKD","LU0289739699.SGD","LU0058720904.USD","IBBQ","BK4585","LU0889565916.HKD","LU1023059063.AUD","PJP","IE00BJJMRZ35.SGD","BBH","IE00BFTCPJ56.SGD","AMGN","LU2242652126.USD","LU1057294990.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111756325","title":"安进股价或创二十余年来最大单日跌幅","url":"https://stock-news.laohu8.com/highlight/detail?id=1111756325","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111756325?lang=zh_cn&edition=full","pubTime":"2026-09-09 02:23","pubTimestamp":1788891793,"startTime":"0","endTime":"0","summary":"安进公司股价近期重挫逾9%，这一跌幅令这家生物技术巨头有望迎来自2000年10月以来最惨淡的单日表现。此番暴跌的导火索，源于诺华制药宣布其心脏病药物pelacarsen在降低心血管事件风险方面未能优于安慰剂，试验宣告失败。周二，礼来股价小幅下挫1.9%。安进的跌势因BMO资本市场的下调评级而进一步加剧，使其沦为标普500指数和纳斯达克100指数中的最大输家。","market":"hk","thumbnail":"https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/95977f976807e41662cc4b3ba02269af"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0122379950.USD","LU1571399168.USD","LU0889565916.HKD","AMGN","PJP","BK4533","BK4599","IE0009355771.USD","SG9999001440.SGD","LU0289739699.SGD","LU2242652126.USD","BK4566","IBB","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","BIB","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","04332","BK4139","LU0109394709.USD","LU0320765992.SGD","BK4585","PBE","LU0058720904.USD","LU2468319806.SGD","LU1061106388.HKD","BK4588","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1983299246.USD","BBH","LU2242646821.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375527","title":"安进股价下跌7%，创下自2025年6月以来最大单日跌幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665375527?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:30","pubTimestamp":1788874246,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1023059063.AUD","IBBQ","AMGN","LU0889565916.HKD","BK4588","LU0320765992.SGD","IBB","LU0868494617.USD","LU0058720904.USD","BK4139","PBE","BK4533","BIB","IE0002141913.USD","IE00B4R5TH58.HKD","LU1983299246.USD","IE0009355771.USD","BK4566","LU0109394709.USD","BK4581","SG9999001440.SGD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU2242646821.SGD","LU2468319806.SGD","PJP","LU1571399168.USD","TBXU","BBH","LU2242652126.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4599","LU2112291526.USD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115495471","title":"安进Phase 3 Dellphi-305研究重大突破：总生存期获益显著优于度伐利尤单抗单药治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1115495471","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115495471?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:07","pubTimestamp":1788872830,"startTime":"0","endTime":"0","summary":"安进公司宣布，其Phase 3 Dellphi-305临床研究取得重大成果——与度伐利尤单抗单独用药相比，该疗法在总生存期上展现出显著且具有临床意义的改善。这一里程碑式的发现，无疑为肿瘤治疗领域注入了新的活力与希望。尽管完整的详细数据尚未全面披露，但安进方面表示，其临床意义及安全性特征将在即将召开的重大学术会议上进行详尽报告。安进公司并未止步于此。随着研发管线的持续推进，安进正逐步兑现其以创新疗法攻克严重疾病的承诺。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0058720904.USD","LU2112291526.USD","LU0289739699.SGD","LU0868494617.USD","IBBQ","IE00BJT1NW94.SGD","LU2468319806.SGD","PBE","BK4588","LU0122379950.USD","TBXU","IE00B4R5TH58.HKD","AMGN","IE00B2B36J28.USD","LU0109394709.USD","LU1571399168.USD","LU1061106388.HKD","IE0002141913.USD","SG9999001440.SGD","LU1057294990.SGD","BK4585","IE00BFTCPJ56.SGD","IBB","BK4533","BIB","BK4599","IE0009355771.USD","LU1023059063.AUD","LU2242646821.SGD","BBH","LU2089984988.USD","LU1983299246.USD","BK4581","LU0889565916.HKD","BK4534","LU2242652126.USD","LU0320765992.SGD","BK4566","PJP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109517247","title":"Imdelltra®联合Imfinzi®在一线广泛期小细胞肺癌中展现里程碑式总生存期改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1109517247","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109517247?lang=zh_cn&edition=full","pubTime":"2026-09-08 21:04","pubTimestamp":1788872687,"startTime":"0","endTime":"0","summary":"Imdelltra®与Imfinzi®的联合疗法，于一线广泛期小细胞肺癌治疗领域，取得了具有划时代意义的总生存期提升。这一突破性进展，不仅为患者带来了新的曙光，也重塑了该领域的治疗格局。从数据层面观察，联合治疗方案的生存获益尤为显著，堪称里程碑式的成就。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU2242652126.USD","PJP","BK4533","LU1061106388.HKD","BK4139","LU0289739699.SGD","LU0122379950.USD","TBXU","SG9999001440.SGD","AMGN","BK4588","IE00BJJMRZ35.SGD","LU0058720904.USD","IE0009355771.USD","BK4534","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IBB","LU0889565916.HKD","BK4581","LU2112291526.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","BK4566","BK4585","BIB","LU0109394709.USD","IBBQ","BK4599","BBH","LU2468319806.SGD","LU2089984988.USD","IE0002141913.USD","LU0868494617.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2242646821.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665387373","title":"BMO下调安进及BioNTech评级至“与大市同步”","url":"https://stock-news.laohu8.com/highlight/detail?id=2665387373","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665387373?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:59","pubTimestamp":1788872377,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BIB","AMGN","LU1061106388.HKD","LU2242646821.SGD","BK4566","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4585","LU1023059063.AUD","IE00BJT1NW94.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2468319806.SGD","IBB","BK4533","LU0122379950.USD","IE00B2B36J28.USD","BK4139","LU0868494617.USD","LU1983299246.USD","BK4588","LU2112291526.USD","IE0002141913.USD","LU2242652126.USD","BBH","IBBQ","BK4581","IE0009355771.USD","LU1057294990.SGD","LU1571399168.USD","PJP","LU0289739699.SGD","SG9999001440.SGD","LU0320765992.SGD","BK4534","LU2089984988.USD","PBE","LU0109394709.USD","BK4599","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103332998","title":"美股盘前｜英特尔、甲骨文涨超4%；诺华重挫12%，IONIS下跌10%；阿斯麦新一代EUV光刻机获台积电和三星使用承诺","url":"https://stock-news.laohu8.com/highlight/detail?id=1103332998","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103332998?lang=zh_cn&edition=full","pubTime":"2026-09-08 20:01","pubTimestamp":1788868860,"startTime":"0","endTime":"0","summary":"9月8日美元指数上升0.0364%，报98.96。03 要闻1. 三大芯片厂全面采购ASML最先进High NA EUV光刻机以扩产高端制程。ASML确认三星、台积电与英特尔已承诺在2028–2030年起量产使用High NA设备，并与ASML签订光罩尺寸升级合作协议，助力降低AI芯片制造成本。","market":"hk","thumbnail":"https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ed4ee39e6b0f45214393093d70ba81a8"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2041044095.USD","LU0823417653.USD","LU0056508442.USD","LU0541501648.USD","LU1093756325.SGD","OZEM","BK4141","LU0976567544.SGD","LU1069347547.HKD","LU2505996509.AUD","IE0004086264.USD","LU1804176565.USD","IGV","LU0070217475.USD","LU1983299246.USD","LU1150488218.USD","CGDG","LU0950375773.USD","LU2129689431.USD","LU0359202008.SGD","LU0889566641.SGD","LU0124676726.USD","LU0278409577.USD","SG9999013999.USD","LU2125154935.USD","BK4548","LU2087621335.USD","SGXZ57979304.SGD","BK4599","LU0061474960.USD","IE00BLSP4452.SGD","LU0345774391.USD","IE00BHPRN162.USD","LU1718418525.SGD","BK4535","LU0861579265.USD","LU1732800096.USD","LU0823414551.USD","LU2129689514.USD","LU0868494617.USD","IE00B19Z3581.USD","EFA","BK4526","LU2089283258.USD","LU2362541513.USD","LU2543165471.USD","IE00BQXX3C00.GBP","TTEQ","FDTX","LU2458330243.SGD","LU2360108059.USD","LU0868494708.USD","BK4566","SG9999001440.SGD","LU2023250504.SGD","LU2506951958.HKD","AIQ","LU0878005551.USD","LU0289739699.SGD","LU1803068979.SGD","SG9999014575.USD","XLE","BK4201","DDM","LU0130103400.USD","LU0823434583.USD","LU1064131342.USD","BBH","LUMA","LU2491050154.USD","LU1366192091.USD","LU2764262908.HKD","LU0300736062.USD","LU1989772923.USD","LU1585245621.USD","LU1778281490.HKD","FTXL","LU1066053197.SGD","LU2931357623.SGD","LU0345770308.USD","LU0234570918.USD","ADVE","LU0823416689.USD","LU1282649067.USD","QQQA","LU0795875086.SGD","03145","CHPX","LU2242649171.HKD","LU1894683348.USD","LU2430703251.USD","LU0654597011.USD","LEGR","LU2264538146.SGD","LU0545039389.USD","LU0081259029.USD","WEEI","BK4503","LU1868838027.USD","LU1992135472.HKD","LU1935042488.USD","PPH","LU0572939691.SGD","LU0345770993.USD","LU1282649810.SGD","INTW","LU2362540622.SGD","SPTE","BK4570","LU0368265418.SGD","LU1023057109.AUD","LU2211814178.USD","LU0211327993.USD","LU0965509101.SGD","LU2237443549.SGD","LU0476273544.USD","LU0122379950.USD","LU2360032135.SGD","LU0109392836.USD","BK4554","LU1868837565.USD","BK4528","IE00BQXX3F31.USD","LU1974910355.USD","BK5113","BK4007","PXI","IE00BFXG1179.USD","LU2063271972.USD","TRUN","AVEM","LU0238689110.USD","IE000SO60NU8.SGD","BK4097","LU2462611646.USD","SOXX","CHPS","SG9999002232.USD","LU0162691827.USD","LU2896262040.SGD","WQTM","LU0256863811.USD","LU0143863784.USD","LU2244417387.USD","LU0048573561.USD","SG9999000418.SGD","LU2487616109.SGD","LU0070302665.USD","LU1935043536.SGD","LU1046421795.USD","LU0957791311.USD","LU0251132253.USD","IE00BN8TJ469.HKD","IYE","EPAI","LU0345769631.USD","LU0444973449.USD","IXC","IE00BBT3K403.USD","LU1989764748.USD","LU2764263203.CNY","LU0466842654.USD","LU1267930227.SGD","LU0094547139.USD","CRAK","BK4534","BK4516","BLOX","BK4148",".DJI","LU2324357040.USD","LU1917777945.USD","ASIA","INT","LU1791710582.SGD","LU2505996681.GBP","LU0210528500.USD","IE00B7SZL793.SGD","QTUP","LU2473716301.USD","LU1861215975.USD","LU1435385759.SGD","LU2271345857.HKD","LU0738911758.USD","LU0882574055.USD","LU1935042991.SGD","LU0882747503.HKD","LU2102340556.USD","BK4578","LU0553294199.USD","BK4532","LU1815336760.USD","IE00B19Z4B17.USD","LU0742534661.SGD","LU2471134879.HKD","OILT","LU2089984988.USD","LU1582986359.USD","LU0359201612.USD","LU2023251221.USD","LU0965509010.AUD","ASMH","LU0496365809.HKD","BK4023","ERX","LU0274383776.USD","DBEF","LU2360106780.USD","LU1489326972.SGD","IE00BZ1G4Q59.USD","TDIV","IBBQ","IE00B5949003.HKD","LU0314106906.USD","LU0114720955.EUR","LU0143863198.USD","IE00BFXG0V08.USD","PQNT","LU0097036916.USD","LU0149725797.USD","LU1791710400.SGD","CHAT","IE0002141913.USD","LU0795875169.SGD","ORCU","LU0109394709.USD","LU2491049909.HKD","LU0648000940.SGD","CGNG","LU0072461881.USD","LU0208291251.USD","LU0266512127.USD","BK4504","LU0321505439.SGD","LU0157215616.USD","LU0823038988.USD","LU1935043023.USD","RSPG","DRIV","LU0942090050.USD","LU1929549753.HKD","LU0630314457.HKD","LU2108987350.USD","LU0345769128.USD","IFLR","LU2360107168.USD","LU1935042215.USD","IE00BMPRXQ63.HKD","LU2237443622.USD","LU2491050071.SGD","LU0011850046.USD","LU0417517546.SGD","LU0052756011.USD","LU0985489474.SGD","LU2720916845.USD","VDE","LU2357627491.SGD","IE00BWXC8680.SGD","SGXZ99366536.SGD","LU0084288322.USD","BIB","LU1150488135.SGD","SMH","CTEX","LU0170899867.USD","LU1712237335.SGD","LU1883866441.USD","BK4170","LU2430703178.SGD","LU2236285917.USD","LU0211328371.USD","LU2592432038.USD","LU1674673428.USD","LU2663582299.SGD","SPWO","HYDR","LU0541502299.USD","LU1674673691.USD","LU2111349929.HKD","LU2148611432.USD","IE00BD6J9T35.USD","LU0068578508.USD","LU2471134796.USD","IE00BZ199S13.USD","LU2357305700.SGD","LU0138981039.USD","AVXC","CNAV","IE00B7SZLL34.SGD","LU0889565916.HKD","LU2750360641.GBP","BK4157","LU1894683264.USD","FENI","BK4575","LU0211331839.USD","LU0345781412.USD","IE00BMPRXN33.USD","LU0868486357.SGD","LU0823039010.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","PJP","LU1571399168.USD","LU2506951875.HKD","OGIG","LU1366333091.USD","LU1323610961.USD","ESIM","LU0077335932.USD","LU0225283273.USD","IE000M9KFDE8.USD","LU1093756168.USD","LU2326559502.SGD","IE000BZT7R73.USD","TEK","LU1023059063.AUD","GNMX","LU0320765992.SGD","LU0058720904.USD","03165","LU1582987597.SGD","LU1003077747.HKD","LU2092937221.SGD","LU0642271901.SGD","IE00B1XK9C88.USD","IE0002270589.USD","LU0128525689.USD","LU0689626769.HKD","LU2089284900.SGD","LU1642822529.SGD","LU1989771016.USD","SG9999004220.SGD","SG9999002224.SGD","LU1720051017.SGD","IEO","LU1066051498.USD","LU0612318385.USD","LU0300736492.USD","SPY","LU2250418816.HKD","IE00B775SV38.USD","IE000WAW04H5.SGD","LU2028103732.USD","IE00BLSP4239.USD","LU1429558221.USD","LU0175139822.USD","LU0154245673.USD","LU0823421416.USD","LU0029874061.USD","LU2471134952.CNY","LU0965508806.USD","EMC","LU1153585028.USD","SG9999014567.USD","LU2272731782.SGD","LU2087625088.SGD","GXPE","SGXZ81514606.USD","LU0289960550.SGD","LU0264606111.USD","BK7095","BK4533","LU0154236417.USD","LU0878004406.USD","LU1057294990.SGD","ILOW","LU2054465674.USD","LU2237443382.USD","BK4538","LU1201861165.SGD","IE0009356076.USD","IE0031619046.USD","IE000MB6IJN5.SGD","DOG","LU2746668461.USD","LU1506573853.SGD","LU2764263039.SGD","BK4121","ORCX","AIS","FENY","LU1074936037.SGD","IEFA","SG9999011175.SGD","IE00BKVL7J92.USD","LU1732799900.SGD","DRLL","LU2602419157.SGD","BK4529","DIG","LU1989764664.SGD","IBB","HK0000304797.USD","LU0267386448.USD","IE00B3M56506.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU2471134523.USD","LU0321505868.SGD","BK4559","IE00B1BXHZ80.USD","IE00B2Q91V27.USD","LU2506952170.USD","IE0004445239.USD","LU0384037296.USD","THNR","LU0683600562.USD","LU2290526834.HKD","ORCL","LU1316542783.SGD","CQTM","LU0788109394.HKD","LU1548497426.USD","ORAC","BK4505","EGGY","LU1823568750.SGD","TINS","LU0433182093.SGD","DIA","WUGI","LU0488056044.USD","MEMX","DBEU","LU0234572021.USD","LU1720051108.HKD","FOTO","LU0348723411.USD","LU0210536198.USD","LU0203345920.USD","LINT","AVSE","BK4213","BK4605","BGIA","TEXU","LU0965509283.SGD","LU0320765489.SGD","IE0004091025.USD","PBE","BK4591","LU0612318971.USD","IE00B4R5TH58.HKD","LU2322448791.USD","LU0158827781.USD","LU0823414478.USD","LU2211815571.USD","DXD","LU2272731865.HKD","LU0211326755.USD","LU1037948897.HKD","LU0719512351.SGD","LU0456854461.SGD","LU2430703095.HKD","BK4608","MEDX","SG9999014542.SGD","LU1037948541.HKD","LU1508157978.USD","LU1211504680.USD","IE00B19Z3B42.SGD","LU2506951792.HKD","SGXZ51526630.SGD","PXE","LU2322448957.HKD","LU0130517989.USD","BK4543","LU0256331488.USD","LU0353189763.USD","LU1868837722.USD","LU2462591277.SGD","LU0359201885.HKD","LU1691799644.USD","LU0310800965.SGD","FTXN","IE0000B7K699.USD","BK4527","LU1861220033.SGD","LU0320765646.SGD","SG9999015358.SGD","BK4588","NVS","INYY","LU0353189680.USD","LU2954938101.SGD","BK4550","IE0034235303.USD","EMM","IGE","ORCS","SG9999001176.SGD","LU2237443978.SGD","IE00B3CCJ963.GBP","LU1582987324.SGD","LU1582986433.USD","LU0889565833.HKD","GNOM","CGGO","HBMX","LU2265009873.SGD","SG9999015341.SGD","TBXU","LU1430594728.SGD","LU1061106388.HKD","LU1934455194.USD","HK0000304805.HKD","LU0572940350.SGD","SG9999003800.SGD","IE00B3S45H60.SGD","LU2746668974.SGD","LU0431992006.USD","LU2294711713.HKD","LU0648001328.SGD","LU1048588211.SGD","LU2506952097.USD","SG9999001424.SGD","SDOW","LU0053666078.USD","BK4602","UDOW","LU0143551892.USD","LU0154245756.USD","CGIC","TNGY","SG9999014559.SGD","LU1934455277.USD","LU0859254822.USD","LU0198837287.USD","LU1815333072.USD","LU2498475776.HKD","IE0009355771.USD","LU0477156953.USD","LU1934455863.HKD","BK4581","LU0082616367.USD","LU2362541273.HKD","LU2860962120.EUR","LU2999663052.SGD","LU1989772840.SGD","LU2242646821.SGD","BK4592","LU2272731600.USD","LU2242652126.USD","LU0122376428.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU2237957902.USD","IE00BKPKM429.USD","CNEQ","IE00BQXX3D17.EUR","IE00BJJMRZ35.SGD","LU0957808578.USD","XNTK","LU0323591593.USD","LU2112291526.USD","LU0792757196.USD","LU2347655156.SGD","SG9999001176.USD","LU1992135399.USD","LU2133065610.SGD","SPRX","LU1430597077.USD","LU0203347892.USD","FFGX","LU0787776722.HKD","IE00BYQQ9H92.USD","LU0187121727.USD","INTC","LU1267930490.SGD","FCG","LU0661504455.SGD","LU1235294995.USD","LU2129689605.HKD","BK4612","LU0980610538.SGD","BK4082","LU1162221912.USD","BAI","LU0823421333.USD","LU1852331112.SGD","LU1623119135.USD","LU1734074674.USD","LU0949170772.SGD","LU0048584097.USD","IE00BGHQF524.EUR","LU0345774631.USD","LU0251142724.SGD","LU0266512473.USD","LU0823417737.USD","SG9999002521.SGD","IE00BMPRXR70.SGD","BK4512","LU0072462343.USD","LU0128526141.USD","GSID","BK4147","UMMA","BK4515","LU0823434740.USD","LU0098860793.USD","IE00B2B36J28.USD","LU2106854487.HKD","LU2249611893.SGD","LU0158827948.USD","BK7104","LU2458330169.SGD","LU1035773651.USD","IE00BSNM7G36.USD","BK4579","LU2357125470.USD","LU1988902786.USD","LU2089985449.USD","BK4139","KNOW","LU0444971666.USD","LU0211326839.USD","LU2298321311.HKD","LU2750360997.AUD","CORO","LU1839511570.USD","LU2237957811.SGD","LU2468319806.SGD","LU0528227936.USD","LU1291159041.SGD","LU0130102774.USD","LU0266013472.USD","LU0251131958.USD","BK4138","BK4585","CWI","LU0912757837.SGD","LU0310799852.SGD","LU0345780950.USD","LU0878866978.SGD","ORCZ","IE00B5TLWC47.USD","IE000F7OJYX1.SGD","IE00B66KJ199.SGD","LU2247934214.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665326953","title":"美股异动｜安进盘前跌5.4%，诺华同靶点药物III期临床失败，Lp(a)赛道遭重创","url":"https://stock-news.laohu8.com/highlight/detail?id=2665326953","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665326953?lang=zh_cn&edition=full","pubTime":"2026-09-08 17:07","pubTimestamp":1788858422,"startTime":"0","endTime":"0","summary":"消息面上，诺华于9月4日公布，其与Ionis联合开发的降脂药物Pelacarsen，在名为LpHORIZON的III期临床试验中未能达到主要终点。诺华的Pelacarsen是全球首个针对Lp靶点进行心血管结局验证的III期药物。因此，市场担忧情绪蔓延到了同样在开发Lp药物的安进身上。多家分析机构认为，诺华的失败削弱了但并未完全推翻Lp这一靶点的可行性。安进后续公布的Olpasiran完整试验数据，将成为判断该靶点未来走向的关键。","market":"sh","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908512020.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260908/32363493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["PJP","SG9999001440.SGD","LU0868494617.USD","LU0320765489.SGD","LU0320765992.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","PPH","IBBQ","LU2242652126.USD","BK4578","LU0211331839.USD","LU2112291526.USD","TBXU","BK4139","IBB","LU2089984988.USD","LU0208291251.USD","BK4566","BBH","LU1983299246.USD","LU1571399168.USD","LU0109394709.USD","MEDX","PBE","LU2468319806.SGD","BK4007","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4581","AMGN","BIB","IE00B4R5TH58.HKD","NVS","BK4599","IE00BJT1NW94.SGD","LU0122379950.USD","LU0289739699.SGD","BK4532","LU0058720904.USD","LU1061106388.HKD","BK4534","LU1023059063.AUD","BK4533","BK4585","BK4588","LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665258833","title":"安进股价盘前下跌5.4%；竞争对手诺华的胆固醇药物后期临床试验失败。","url":"https://stock-news.laohu8.com/highlight/detail?id=2665258833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665258833?lang=zh_cn&edition=full","pubTime":"2026-09-08 16:28","pubTimestamp":1788856084,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","MDTX","PPH","LU0889565916.HKD","BBH","BK4534","LU0122379950.USD","BIB","LU0211331839.USD","BK4007","IBBJ","LU2089984988.USD","SG9999001440.SGD","BK4585","BK4533","BK4578","IBBQ","LU1023059063.AUD","LU2468319806.SGD","IE00BJT1NW94.SGD","NVS","BMED","IE0002141913.USD","LU0320765489.SGD","LU0109394709.USD","LU2242646821.SGD","LU0070302665.USD","LU1061106388.HKD","IBB","LU0320765992.SGD","BK4532","BK4566","LU2242652126.USD","TBXU","LU2112291526.USD","LU1057294990.SGD","AMGN","LU0058720904.USD","PSYK","MEDX","BK4599","IE00BJJMRZ35.SGD","LU0289739699.SGD","PJP","BK4581","LU0868494617.USD","LU1983299246.USD","PBE","LU0208291251.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665349003","title":"富国银行上调安进目标价至435美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665349003","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665349003?lang=zh_cn&edition=full","pubTime":"2026-09-08 11:12","pubTimestamp":1788837128,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1023059063.AUD","BK4599","LU2242652126.USD","BK4582","IBB","AMGN","UUP","BK4533","LU2112291526.USD","LU2089984988.USD","TBXU","LU0058720904.USD","LU0320765992.SGD","BK4534","BK4581","IE00BJJMRZ35.SGD","BK4139","LU0289739699.SGD","PGF","IE0009355771.USD","IE00B4R5TH58.HKD","IBBQ","PBE","LU2242646821.SGD","IE0002141913.USD","LU1571399168.USD","BIB","LU2468319806.SGD","BK4588","IE00BJT1NW94.SGD","SG9999001440.SGD","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU0889565916.HKD","BK4585","LU0109394709.USD","LU1061106388.HKD","PJP","IE00B2B36J28.USD","UDN","BK4566","BBH","LU0122379950.USD","LU0868494617.USD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392789","title":"一周两度受挫！诺华(NVS.US)心脏病重磅药III期折戟，股价大跌安进(AMGN.US)“躺枪”","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392789","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665392789?lang=zh_cn&edition=full","pubTime":"2026-09-07 15:15","pubTimestamp":1788765302,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞士制药巨头诺华制药再遭临床试验打击——一周之内，该公司第二项重磅候选药物在后期研究中折戟。此次失利的是其潜在明星心脏病药物pelacarsen。受此消息影响，诺华在美上市股票上周五常规交易结束后一度下跌逾7%。开发类似心脏药物的安进股价上周五盘后也下挫近6%。诺华正寄望于一系列新药来支撑增长，以应对旗下多款重磅产品专利即将到期的压力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","LU1057294990.SGD","IBBQ","BK4533","LU2242652126.USD","IE0009355771.USD","BK4007","LU2468319806.SGD","LU0320765992.SGD","NVS","BK4581","LU0070302665.USD","BK4139","LU0211331839.USD","PPH","IE00B2B36J28.USD","MEDX","BK4532","IE00BJT1NW94.SGD","LU2089984988.USD","IE0002141913.USD","LU2112291526.USD","BK4534","LU1571399168.USD","IBB","BK4599","BK4566","IE00BJJMRZ35.SGD","BBH","LU1061106388.HKD","BK4578","LU1023059063.AUD","SG9999001440.SGD","BIB","PBE","AMGN","LU0868494617.USD","IE00B4R5TH58.HKD","BK4588","LU0208291251.USD","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","LU0320765489.SGD","LU0122379950.USD","PJP","LU2242646821.SGD","LU0889565916.HKD","LU0289739699.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194645441","title":"Stoke Therapeutics与渤健在第16届欧洲癫痫大会上公布Zorevunersen长期临床数据，力证Dravet综合征治疗药物的疾病修饰潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=1194645441","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194645441?lang=zh_cn&edition=full","pubTime":"2026-09-04 07:31","pubTimestamp":1788478271,"startTime":"0","endTime":"0","summary":"Stoke Therapeutics与渤健公司于第16届欧洲癫痫大会上联合呈现了Zorevunersen的长期临床数据，这些数据有力支持了这款用于治疗Dravet综合征的在研药物所具备的疾病修饰潜力。Zorevunersen作为一种实验性疗法，其最新公布的长期随访结果备受业界关注。此次大会上披露的数据，进一步印证了该药物在改变Dravet综合征疾病进程方面的可能性，为这一罕见且严重的癫痫性脑病治疗领域带来了新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","IE00B19Z9P08.USD","BK4585","IE00B894F039.SGD","BIIB","BK4139","LU0889565916.HKD","BK4533","PBE","BK4532","IE00B19Z9Z06.USD","LU0234570918.USD","BK4588","LU0320765992.SGD","STOK","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664333811","title":"梯瓦制药（TEVA）与Royalty Pharma（RPRX）合作抗体药物TEV'408迎重大临床突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2664333811","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664333811?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:07","pubTimestamp":1788350836,"startTime":"0","endTime":"0","summary":"金吾财讯 | 梯瓦制药 与Royalty Pharma宣布，双方合作开发的抗白细胞介素-15抗体药物TEV'408在治疗成人乳糜泻的2a期临床试验中取得积极结果。在给药第8周时，与安慰剂组相比，TEV'408在统计学上显著且临床上有效地预防了由麸质诱发的肠道损伤。根据“乳糜泻症状日记”显示，接受TEV'408治疗的患者其胃肠道症状评分明显低于安慰剂组。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODY4OWQ3Mzc3NDBiZmZiN2U4NjgyMDY5NTE3ODY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305631","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4559","BK4584","LU1983299246.USD","LU2324357040.USD","IHE","PBE","TEVA","RPRX","BK4557","BK4585","BK4566","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664194548","title":"安进（AMGN）罕见病药物Tavneos将于27年3月1日被彻底撤销英国上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2664194548","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664194548?lang=zh_cn&edition=full","pubTime":"2026-09-02 19:59","pubTimestamp":1788350357,"startTime":"0","endTime":"0","summary":"金吾财讯 | 英国药品监管机构MHRA宣布，暂停安进（AMGN）罕见病药物Avacopan Vifor（原商品名Tavneos）用于新患者，监管认定支撑该药物获批的关键临床试验数据已不可靠。该药2022年在英国获批，用于治疗两种罕见血管炎症自身免疫病。安进持有美国地区权益，由CSL集团（CSLLY）旗下CSLVifor负责英国等海外市场销售。新规9月1日落地，不再允许新患者启用该药物；为保障现有患者安全，设置6个月过渡用药期，2027年3月1日将彻底撤销其英国上市许可，现有患者可在此期间逐步更换替代治疗方案。安进方面公开表示不认可监管机构的决定，担忧该举措会对罕见病患者造成负面影响。","market":"fut","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"305627","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","BIB","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","PJP","IPOS","IE0009355771.USD","BK4533","AMGN","LU0320765992.SGD","BK4581","PBE","TBXU","LU1983299246.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00B2B36J28.USD","LU2242646821.SGD","LU0889565916.HKD","LU1023059063.AUD","LU2089984988.USD","BK4139","AZNH","LU2242652126.USD","LU2112291526.USD","LU0122379950.USD","LU1061106388.HKD","LU2468319806.SGD","LU0868494617.USD","BK4599","BK4534","IBBQ","LU1057294990.SGD","BK4566","BBH","BK4585","LU0289739699.SGD","LU1571399168.USD","LU0109394709.USD","IE00BFTCPJ56.SGD","BK4588","LU0058720904.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891714","title":"高盛9月“确信名单”更新：美股纳入福泰制药(VRTX.US) 欧股力推莱茵、Adyen和塔兰克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891714","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664891714?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNMX","IDNA","IE0002141913.USD","LU0289739699.SGD","BK4585","LU2237438978.USD","LU0061475181.USD","TBXU","LU0096364046.USD","BBH","LU2237443549.SGD","LU2324357040.USD","IE00BJJMRZ35.SGD","LU1868836591.USD","BIB","LU1791807156.HKD","LU2456880835.USD","IE00BZ9MQY76.HKD","LU0868494708.USD","BK4127","LU0868494617.USD","LU1668664300.SGD","LU0251131958.USD","SG9999001176.SGD","IE0009355771.USD","IEV","LU2468319806.SGD","IBBQ","LU1674673691.USD","LU2471134523.USD","LU2462157665.USD","BK4533","BK4550","LU2471134952.CNY","VRTX","LU1868837300.USD","IBB","VXUS","LU0432979614.USD","IE00B19Z9P08.USD","LU1868836914.USD","IE00B19Z9Z06.USD","VGK","GSX","PBE","BK4588","LU0942090050.USD","SG9999001176.USD","LU2237443978.SGD","LU1144417596.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664891705","title":"高盛9月“确信名单”更新：美股纳入福泰制药 欧股力推莱茵、Adyen和塔兰克斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2664891705","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664891705?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:20","pubTimestamp":1788333621,"startTime":"0","endTime":"0","summary":"进入秋季，高盛对其美国及欧洲市场的“确信名单”进行了更新，为投资者指明当前最看好的股票方向。本次调整中，美国名单新增一只大型生物科技股，欧洲名单则迎来三家新面孔。美国名单：新增福泰制药，移除盈透证券在美国市场，高盛将 $福泰制药$纳入确信名单，同时移除了 $盈透证券$，调整后名单保留23只股票。高盛还表示，塔兰克斯的国际零售业务是被低估的增长引擎。","market":"us","thumbnail":"https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/1b3684302211042d481cacf9066fbcca"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490866.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2237443549.SGD","BIB","SG9999001176.USD","LU2236285917.USD","GSX","IE0034235188.USD","SG9999001176.SGD","VRTX","LU0345770993.USD","LU2471134796.USD","MSFU","IBB","LU2471134523.USD","BK4533","VGK","BBH","MSFO","MSFX","GNMX","LU0106831901.USD","XYZY","WFC","LU2362541273.HKD","IE00BJT1NW94.SGD","IE0002270589.USD","EL","VXUS","MSFC","IDNA","LU2471134952.CNY","IE00B2B36J28.USD","CRNX","LU2417539215.USD","IBKR","LU1868836757.USD","UNHU","UNH","IE00BFXG1179.USD","LU2468319806.SGD","IE0004091025.USD","UNHW","LU1585245621.USD","TBXU","UN","LU2471134879.HKD","XYZ","DAL","BK4532","IE00B19Z3581.USD","IEV","XYZG","MSFT","BK4504","LU0432979614.USD","LU2750360641.GBP","BK4585","LU0889565916.HKD","COP","MSFW","MSFL","UNHG","PBE","LU0109394709.USD","LU1868837300.USD","LU1868837136.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","IBBQ","LU1069344957.HKD","MSFY","LU2456880835.USD","MSFD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.013},{"period":"1month","weight":-0.0142},{"period":"3month","weight":0.1031},{"period":"6month","weight":0.2252},{"period":"1year","weight":0.34},{"period":"ytd","weight":0.1366}],"compareEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0241},{"period":"3month","weight":0.0098},{"period":"6month","weight":0.1626},{"period":"1year","weight":0.1425},{"period":"ytd","weight":0.1058}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.018649},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.004391},{"month":3,"riseRate":0.47619,"avgChangeRate":-0.002718},{"month":4,"riseRate":0.52381,"avgChangeRate":0.005803},{"month":5,"riseRate":0.619048,"avgChangeRate":0.008753},{"month":6,"riseRate":0.666667,"avgChangeRate":0.018605},{"month":7,"riseRate":0.636364,"avgChangeRate":0.038738},{"month":8,"riseRate":0.590909,"avgChangeRate":0.010947},{"month":9,"riseRate":0.363636,"avgChangeRate":-0.013943},{"month":10,"riseRate":0.52381,"avgChangeRate":-0.006664},{"month":11,"riseRate":0.714286,"avgChangeRate":0.035033},{"month":12,"riseRate":0.47619,"avgChangeRate":0.000122}],"exchange":"ARCA","name":"INVESCO BIOTECHNOLOGY & GENOME ETF","nameEN":"INVESCO BIOTECHNOLOGY & GENOME ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"INVESCO BIOTECHNOLOGY & GENOME ETF,PBE,INVESCO BIOTECHNOLOGY & GENOME ETF股票,INVESCO BIOTECHNOLOGY & GENOME ETF股票老虎,INVESCO BIOTECHNOLOGY & GENOME ETF股票老虎国际,INVESCO BIOTECHNOLOGY & GENOME ETF行情,INVESCO BIOTECHNOLOGY & GENOME ETF股票行情,INVESCO BIOTECHNOLOGY & GENOME ETF股价,INVESCO BIOTECHNOLOGY & GENOME ETF股市,INVESCO BIOTECHNOLOGY & GENOME ETF股票价格,INVESCO BIOTECHNOLOGY & GENOME ETF股票交易,INVESCO BIOTECHNOLOGY & GENOME ETF股票购买,INVESCO BIOTECHNOLOGY & GENOME ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供INVESCO BIOTECHNOLOGY & GENOME ETF(PBE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}